Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-07

Clinical Trial Update: Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057) [Phase 1]

View source ↗

Summary

Phase 1 trial updates tolerability and efficacy of ibuprofen 800 mg in a walking model of knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED | Results posted: 2009-07-07